Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (A.C.O., M.C.H.).
Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD (E.D.M.).
Circ Res. 2022 Feb 18;130(4):652-672. doi: 10.1161/CIRCRESAHA.121.319895. Epub 2022 Feb 17.
Beyond conventional risk factors for cardiovascular disease, women face an additional burden of sex-specific risk factors. Key stages of a woman's reproductive history may influence or reveal short- and long-term cardiometabolic and cardiovascular trajectories. Early and late menarche, polycystic ovary syndrome, infertility, adverse pregnancy outcomes (eg, hypertensive disorders of pregnancy, gestational diabetes, preterm delivery, and intrauterine growth restriction), and absence of breastfeeding are all associated with increased future cardiovascular disease risk. The menopause transition additionally represents a period of accelerated cardiovascular disease risk, with timing (eg, premature menopause), mechanism, and symptoms of menopause, as well as treatment of menopause symptoms, each contributing to this risk. Differences in conventional cardiovascular disease risk factors appear to explain some, but not all, of the observed associations between reproductive history and later-life cardiovascular disease; further research is needed to elucidate hormonal effects and unique sex-specific disease mechanisms. A history of reproductive risk factors represents an opportunity for comprehensive risk factor screening, refinement of cardiovascular disease risk assessment, and implementation of primordial and primary prevention to optimize long-term cardiometabolic health in women.
除了心血管疾病的传统危险因素外,女性还面临着特定于性别的危险因素的额外负担。女性生殖史的关键阶段可能会影响或揭示短期和长期的心脏代谢和心血管轨迹。初潮早、晚,多囊卵巢综合征,不孕,不良妊娠结局(如妊娠高血压疾病、妊娠期糖尿病、早产和宫内生长受限),以及缺乏母乳喂养,都与未来心血管疾病风险增加有关。绝经期过渡期另外也是心血管疾病风险加速增加的时期,绝经的时机(如过早绝经)、机制和症状,以及绝经症状的治疗,都促成了这种风险。传统心血管疾病危险因素的差异似乎可以解释生殖史与晚年心血管疾病之间的一些关联,但并非全部;需要进一步的研究来阐明激素的影响和独特的性别特异性疾病机制。生殖危险因素史为全面的危险因素筛查、心血管疾病风险评估的细化以及原始和初级预防的实施提供了机会,以优化女性的长期心脏代谢健康。
Circ Res. 2022-2-18
Clin Cardiol. 2018-2
Zhonghua Jie He He Hu Xi Za Zhi. 2024-6-12
Menopause Int. 2013-9
J Womens Health (Larchmt). 2019-8
Cardiovasc Res. 2025-8-28
Alzheimers Dement. 2025-8
Ewha Med J. 2024-4
Am Heart J Plus. 2025-7-2
Nat Cardiovasc Res. 2025-7-11
J Clin Endocrinol Metab. 2022-1-1
J Am Coll Cardiol. 2021-4-13
Hypertension. 2021-5-5